NEW YORK, NY / ACCESSWIRE / August 19, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:
Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.
Megalith Financial Acquisition Corp. (NYSE:MFAC)
Merger Announcement: August 6, 2020
Transaction Details: Under the terms of the merger, the combined company will be named BM Technologies, Inc. and be listed on the NYSE. Following the merger, Customers Bank, the parent company of BankMobile, will be the largest stockholder of the combined company.
To learn more about the MFAC investigation and your rights, go to:
https://www.zlk.com/mna2/megalith-financial-acquisition-corp-information-request-form
Cellular Biomedicine Group, Inc. (NASDAQ:CBMG)
Agreement Announcement: August 12, 2020
Transaction Details: Under the terms of the merger, Cellular Biomedicine stockholders will receive $19.75 in cash for each outstanding share of common stock held immediately prior to the effective time of the merger.
To learn more about the CBMG investigation and your rights, go to:
https://www.zlk.com/mna2/cellular-biomedicine-group-inc-information-request-form
Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
[email protected]
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP